These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38250137)

  • 81. Systemic Corticosteroid-related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis.
    Davis GE; Zeiger RS; Emmanuel B; Chung Y; Tran TN; Evans KA; Chen S; Katial R; Kreindler JL; Tkacz J
    Clin Ther; 2022 Sep; 44(9):1187-1202. PubMed ID: 36057475
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status.
    Rabe KF; Pavord ID; Busse WW; Chupp GL; Izuhara K; Altincatal A; Gall R; Pandit-Abid N; Deniz Y; Rowe PJ; Jacob-Nara JA; Radwan A
    Allergy; 2023 Aug; 78(8):2148-2156. PubMed ID: 37073882
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study
    D'Amato M; Menzella F; Altieri E; Bargagli E; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Caruso C; Centanni S; De Michele F; Di Marco F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Vultaggio A; Ori A; Simoni L; Boarino S; Vitiello G; Aliani M; Del Giacco S
    Front Allergy; 2022; 3():881218. PubMed ID: 35769575
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.
    Sher LD; Wechsler ME; Rabe KF; Maspero JF; Daizadeh N; Mao X; Ortiz B; Mannent LP; Laws E; Ruddy M; Pandit-Abid N; Jacob-Nara JA; Gall R; Rowe PJ; Deniz Y; Lederer DJ; Hardin M
    Chest; 2022 Jul; 162(1):46-55. PubMed ID: 35217003
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 87. The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland.
    Toppila-Salmi S; Hällfors J; Aakko J; Mannerström B; Nieminen K; Telg G; Lehtimäki L
    Clin Transl Allergy; 2022 Oct; 12(10):e12200. PubMed ID: 36246729
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps.
    Koski RR; Hill L; Taavola K
    J Pharm Technol; 2022 Oct; 38(5):289-296. PubMed ID: 36046351
    [No Abstract]   [Full Text] [Related]  

  • 89. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
    De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J;
    Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study.
    Higo H; Ichikawa H; Arakawa Y; Mori Y; Itano J; Taniguchi A; Senoo S; Kimura G; Tanimoto Y; Miyake K; Katsuta T; Kataoka M; Maeda Y; Kiura K; Miyahara N; Okayama Respiratory Disease Study Group Ordsg
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629217
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.
    Galletti C; Ragusa M; Sireci F; Ciodaro F; Barbieri MA; Giunta G; Grigaliute E; Immordino A; Lorusso F; Dispenza F; Freni F; Galletti F; Gallina S; La Mantia I; Galletti B
    Am J Otolaryngol; 2024; 45(1):104106. PubMed ID: 37948824
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cost-utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country.
    Alvarez L; Querubin J; Bedoya J; Mejia A; Sánchez J
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):571-578. PubMed ID: 36976904
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
    Corren J; Hanania NA; Busse WW; Sher LD; Altincatal A; Hardin M; Mannent LP; Amin N; Lederer DJ; Soler X; Jacob-Nara JA; Rowe PJ; Deniz Y
    Clin Exp Allergy; 2023 Oct; 53(10):1020-1030. PubMed ID: 37752621
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
    Bacharier LB; Maspero JF; Katelaris CH; Fiocchi AG; Gagnon R; de Mir I; Jain N; Sher LD; Mao X; Liu D; Zhang Y; Khan AH; Kapoor U; Khokhar FA; Rowe PJ; Deniz Y; Ruddy M; Laws E; Patel N; Weinreich DM; Yancopoulos GD; Amin N; Mannent LP; Lederer DJ; Hardin M;
    N Engl J Med; 2021 Dec; 385(24):2230-2240. PubMed ID: 34879449
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysis.
    Fokkens WJ; Mullol J; Kennedy D; Philpott C; Seccia V; Kern RC; Coste A; Sousa AR; Howarth PH; Benson VS; Mayer B; Yancey SW; Chan R; Gane SB
    Allergy; 2023 Mar; 78(3):812-821. PubMed ID: 35822924
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps.
    Tanzini U; Rampi A; Vinciguerra A; Danè G; Yacoub MR; Bussi M; Trimarchi M
    Eur Arch Otorhinolaryngol; 2024 Jun; ():. PubMed ID: 38850424
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach.
    Seccia V; D'Amato M; Scioscia G; Bagnasco D; Di Marco F; Fadda G; Menzella F; Pasquini E; Pelaia G; Tremante E; De Corso E; Bonini M
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887593
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
    Nolasco S; Crimi C; Pelaia C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Campisi R; Valenti G; Vatrella A; Crimi N
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4371-4380.e4. PubMed ID: 34419679
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The role of intranasal corticosteroids in chronic rhinosinusitis with nasal polyposis treated with dupilumab.
    Pecorari G; Piazza F; Borgione M; Prizio C; Galli Della Mantica G; Garetto M; Gedda F; Riva G
    Am J Otolaryngol; 2023; 44(5):103927. PubMed ID: 37245323
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.